MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Glenmark
Glenmark
BSE: 532296NSE: GLENMARKISIN: INE935A01035

2nd-Aug-2012 15:43Source: BSE

Glenmark - Announces Q1 results, Results Press Release & Limited Review Report for the Quarter ended June 30, 2012

Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended June 30, 2012:

The Unaudited results for the Quarter ended June 30, 2012

The Company has posted a net profit of Rs. 548.25 million for the quarter ended June 30, 2012 as compared to Rs. 724.65 million for the quarter ended June 30, 2011. Total Income has increased from Rs. 3432.46 million for the quarter ended June 30, 2011 to Rs. 4046.97 million for the quarter ended June 30, 2012.

The Consolidated Results are as follows:

The Unaudited results for the Quarter ended June 30, 2012

The Group has posted a net profit after taxes, Minority Interest and Share of Profit of Associate of Rs. 782.75 million for the quarter ended June 30, 2012 as compared to Rs. 2085.85 million for the quarter ended June 30, 2011. Total Income has increased from Rs. 8808.95 million for the quarter ended June 30, 2011 to Rs. 10432.96 million for the quarter ended June 30, 2012.

Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Thursday`s damage may keep mkt edgy for next few days: Udayan Mukherjee. Do you agree?
Yes
No